IL6 and cancer: MSCs release specific molecules such as epidermal growth factors (EGFs) (51), IL-8/IL-6 cytokines (52) and CXCL1/2/12 chemokines (53) which directly act on cancer cells in a paracrine fashion and increase cellular proliferation by induction of phenotypic modification.